Abstract

The present paper describes an ultrasound-assisted synthesis of a series of 4-arylidene-1H-pyrazol-5(4H)-one derivatives (3a-i) catalyzed by sulfamic acid. The prepared compounds were characterized by physical and spectroscopic techniques and for compound 3i by single crystal X-ray diffraction analysis. Theoretical calculations such as molecular structure optimization, frontier molecular orbitals, molecular electrostatic potential, and molecular descriptors have been performed in order to get insight into the molecular structure and chemical reactivity of the synthesized compounds. The antibacterial activity of all compounds was assessed against six bacterial strains, and it was found that these compounds are good inhibitors of Gram-positive bacteria rather than Gram-negative. In addition, good oral bioavailability was predicted for all compounds by in silico calculations of ADME (absorption, distribution, metabolism, and elimination) and pharmacokinetic parameters.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.